Skip to main content

Ballentine Partners, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1374889 Waltham, MA

Position in REGN

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$657,210
-$269,184 QoQ
Shares Held
1,054
-12.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#77
of 179 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ballentine Partners, LLC holds $12,066,429 across 29 Biotechnology names. REGN ranks #4 (5.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
1,054 $657,210

All Filings in REGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $657,210 1,054
2026-03-31 $926,394 1,199
2025-12-31 $856,002 1,109
2025-09-30 $599,378 1,066
2025-06-30 $504,525 961
2025-03-31 $640,571 1,010
2024-12-31 $653,205 917
2024-09-30 $1,116,415 1,062
2024-06-30 $1,063,640 1,012
2024-03-31 $1,000,989 1,040
2023-12-31 $663,107 755
2023-09-30 $819,666 996
2023-06-30 $512,317 713
2023-03-31 $917,804 1,117
2022-12-31 $559,153 775
2022-09-30 $400,232 581
2022-06-30 $205,712 348
2022-03-31 $264,002 378